One Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $560K | Hold |
19,935
| – | – | 0.02% | 372 |
|
|
2026
Q1 | $560K | Sell |
19,935
-15,877
| -44% | -$423K | 0.02% | 369 |
|
|
2025
Q4 | $892K | Sell |
35,812
-355,025
| -91% | -$8.95M | 0.03% | 312 |
|
|
2025
Q3 | $9.96M | Buy |
390,837
+29,932
| +8% | +$739K | 0.32% | 77 |
|
|
2025
Q2 | $8.75M | Buy |
360,905
+35,519
| +11% | +$828K | 0.3% | 82 |
|
|
2025
Q1 | $8.25M | Buy |
325,386
+23,865
| +8% | +$624K | 0.28% | 87 |
|
|
2024
Q4 | $8M | Sell |
301,521
-6,669
| -2% | -$181K | 0.26% | 94 |
|
|
2024
Q3 | $8.92M | Buy |
308,190
+37,509
| +14% | +$1.09M | 0.28% | 92 |
|
|
2024
Q2 | $7.57M | Buy |
270,681
+65,631
| +32% | +$1.81M | 0.26% | 89 |
|
|
2024
Q1 | $5.69M | Buy |
205,050
+22,256
| +12% | +$618K | 0.21% | 104 |
|
|
2023
Q4 | $5.26M | Sell |
182,794
-7,450
| -4% | -$225K | 0.21% | 108 |
|
|
2023
Q3 | $6.31M | Buy |
190,244
+11,070
| +6% | +$391K | 0.28% | 85 |
|
|
2023
Q2 | $6.57M | Buy |
179,174
+12,609
| +8% | +$491K | 0.3% | 82 |
|
|
2023
Q1 | $6.8M | Buy |
166,565
+16,662
| +11% | +$720K | 0.33% | 82 |
|
|
2022
Q4 | $7.68M | Buy |
149,903
+555
| +0.4% | +$26.6K | 0.41% | 65 |
|
|
2022
Q3 | $6.54M | Buy |
149,348
+6,299
| +4% | +$306K | 0.39% | 68 |
|
|
2022
Q2 | $7.5M | Sell |
143,049
-1,445
| -1% | -$73.6K | 0.44% | 58 |
|
|
2022
Q1 | $7.48M | Buy |
144,494
+950
| +0.7% | +$49.3K | 0.4% | 61 |
|
|
2021
Q4 | $8.48M | Buy |
143,544
+4,719
| +3% | +$234K | 0.64% | 36 |
|
|
2021
Q3 | $5.97M | Sell |
138,825
-6,327
| -4% | -$280K | 0.49% | 47 |
|
|
2021
Q2 | $5.68M | Buy |
145,152
+12,552
| +9% | +$488K | 0.5% | 48 |
|
|
2021
Q1 | $4.8M | Buy |
132,600
+16,144
| +14% | +$573K | 0.53% | 55 |
|
|
2020
Q4 | $4.29M | Buy |
116,456
+3,428
| +3% | +$126K | 0.52% | 57 |
|
|
2020
Q3 | $3.94M | Buy |
113,028
+1,562
| +1% | +$54.8K | 0.54% | 51 |
|
|
2020
Q2 | $3.46M | Buy |
111,466
+7,818
| +8% | +$266K | 0.5% | 54 |
|
|
2020
Q1 | $3.21M | Buy |
103,648
+10,259
| +11% | +$350K | 0.54% | 44 |
|
|
2019
Q4 | $3.47M | Buy |
93,389
+5,556
| +6% | +$198K | 0.53% | 47 |
|
|
2019
Q3 | $2.99M | Buy |
87,833
+1,617
| +2% | +$58.8K | 0.5% | 61 |
|
|
2019
Q2 | $3.54M | Sell |
86,216
-12,881
| -13% | -$511K | 0.6% | 44 |
|
|
2019
Q1 | $3.99M | Buy |
99,097
+1,317
| +1% | +$52.7K | 0.71% | 31 |
|
|
2018
Q4 | $4.05M | Sell |
97,780
-2,202
| -2% | -$91.4K | 0.82% | 29 |
|
|
2018
Q3 | $4.18M | Sell |
99,982
-2,233
| -2% | -$86K | 0.76% | 33 |
|
|
2018
Q2 | $3.52M | Buy |
102,215
+589
| +0.6% | +$20.1K | 0.67% | 39 |
|
|
2018
Q1 | $3.42M | Buy |
101,626
+3,286
| +3% | +$113K | 0.67% | 39 |
|
|
2017
Q4 | $3.38M | Buy |
98,340
+1,979
| +2% | +$67.5K | 0.68% | 39 |
|
|
2017
Q3 | $3.26M | Buy |
96,361
+5,236
| +6% | +$168K | 0.68% | 39 |
|
|
2017
Q2 | $2.9M | Buy |
91,125
+3,700
| +4% | +$117K | 0.85% | 35 |
|
|
2017
Q1 | $2.84M | Sell |
87,425
-1,717
| -2% | -$54.1K | 0.88% | 33 |
|
|
2016
Q4 | $2.75M | Buy |
89,142
+1,243
| +1% | +$37.9K | 0.87% | 33 |
|
|
2016
Q3 | $2.83M | Buy |
87,899
+326
| +0.4% | +$10.9K | 0.92% | 31 |
|
|
2016
Q2 | $2.92M | Sell |
87,573
-3,637
| -4% | -$116K | 1.02% | 27 |
|
|
2016
Q1 | $2.56M | Buy |
91,210
+5,689
| +7% | +$163K | 0.1% | 31 |
|
|
2015
Q4 | $2.7M | Sell |
85,521
-944
| -1% | -$29.7K | 0.92% | 29 |
|
|
2015
Q3 | $2.58M | Sell |
86,465
-85
| -0.1% | -$2.73K | 0.94% | 27 |
|
|
2015
Q2 | $2.75M | Buy |
86,550
+3,195
| +4% | +$104K | 0.79% | 33 |
|
|
2015
Q1 | $2.75M | Buy |
83,355
+7,732
| +10% | +$246K | 0.83% | 30 |
|
|
2014
Q4 | $2.23M | Buy |
75,623
+1,938
| +3% | +$55.6K | 0.84% | 37 |
|
|
2014
Q3 | $2.07M | Sell |
73,685
-1,516
| -2% | -$42.5K | 0.74% | 35 |
|
|
2014
Q2 | $2.12M | Buy |
75,201
+1,004
| +1% | +$28.6K | 0.85% | 31 |
|
|
2014
Q1 | $2.26M | Buy |
+74,197
| New | +$2.21M | 0.86% | 31 |
|
Other funds holding PFE
One Capital Management's PFE Position: Q2 2026 in Review
One Capital Management held its Pfizer (PFE) position steady in Q2 2026 at 19,935 shares worth $560K. The position accounts for 0.02% of the portfolio, ranked #372.
One Capital Management first reported a position in PFE in Q1 2014 and has held it in 50 quarters since. The position peaked at $9.96M in Q3 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- One Capital Management held 19,935 shares of Pfizer worth $560K as of Q2 2026.
- One Capital Management left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.02% of One Capital Management's portfolio in Q2 2026, its #372 holding.
- One Capital Management first reported a position in Pfizer in Q1 2014 and has held it in 50 quarters since.
- One Capital Management's Pfizer position peaked at $9.96M in Q3 2025.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on One Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.